Interesting Images18F-PSMA 1007 Uptake in a Man With Metastatic Breast CancerMarafi, Fahad MD, KBNM*; Sasikumar, Arun MD†; Alfeeli, Mahamoud MD, KBNM*; Thuruthel, Sanjay DM‡Author Information From the *Jaber Alahmad Centre for Molecular Imaging, Kuwait City, Kuwait †St Gregorios International Cancer Care Centre, Parumala, Pathanmthitta, India ‡Kuwait Cancer Control Centre, Kuwait City, Kuwait. Received for publication April 29, 2019; revision accepted February 10, 2020. Conflicts of interest and sources of funding: none declared. Correspondence to: Arun Sasikumar, MD, Department of Nuclear Medicine, St Gregorios International Cancer Care Centre, Parumala, Pathanmthitta, Kerala 689622, India. E-mail: firstname.lastname@example.org. Online date: April 23, 2020 Clinical Nuclear Medicine: June 2020 - Volume 45 - Issue 6 - p e276-e278 doi: 10.1097/RLU.0000000000003013 Buy Metrics Abstract A 72-year-old man, who is known with a case of metastatic carcinoma of the breast, was referred for 18F-PMSA 1007 PET/CT with clinical suspicion of synchronous prostate cancer. 18F-PSMA 1007 PET/CT scan detected no abnormal tracer concentrating lesion in the prostate gland; however, abnormal tracer concentration was noted in soft tissue lesions in left breast, metastatic lymph nodes, and skeletal lesions. Compared with 18F-FDG PET/CT, more bone lesions were detected on 18F-PSMA 1007 imaging. The findings of our case open the possibility of imaging metastatic breast cancer with 18F-PSMA 1007 in men. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.